Yamamoto M, Furihata C, Fujimitsu Y, Imai T, Inada K, Nakanishi H, Tatematsu M
Laboratory of Pathology, Aichi Cancer Center Research Institute, Nagoya.
Jpn J Cancer Res. 1997 Mar;88(3):238-44. doi: 10.1111/j.1349-7006.1997.tb00373.x.
The dose-response relation for the appearance of pepsinogen isozyme 1 (Pg 1)-altered pyloric glands (PAPG) and the related induction of adenocarcinomas were examined in male C3H mice given N-methyl-N-nitrosourea (MNU) in their drinking water at the concentration of 120 ppm (group 1), 60 ppm (group 2), 30 ppm (group 3) or 0 ppm (group 4) for 30 weeks and then normal tap water. Animals were killed at weeks 10, 30 and 42. Adenomatous hyperplasias and adenocarcinomas were noted from week 30 and their induction was dose-dependent at week 42. Almost all cells of pyloric gland cell type in those lesions had little or no immunohistochemically demonstratable Pg 1 content, as was also the case for the cells in PAPG, whose numbers per 100 normal-appearing pyloric glands were found to be MNU dose-dependent at all experimental time points. The numbers of PAPG at week 10 significantly correlated with the incidences of adenomatous hyperplasias and adenocarcinomas at week 42. Investigation of proliferation by immunohistochemical detection of bromodeoxyuridine (BrdU) labeling in the PAPG at week 10 demonstrated elevation (P < 0.05) as compared to normal pyloric glands. Intestinal metaplasia was not a feature in the present experiment and the results suggest that in mice, PAPG might be a preneoplastic lesion involved in gastric chemical carcinogenesis.
在雄性C3H小鼠中,研究了胃蛋白酶原同工酶1(Pg 1)改变的幽门腺(PAPG)出现的剂量反应关系以及相关的腺癌诱导情况。这些小鼠饮用含120 ppm(第1组)、60 ppm(第2组)、30 ppm(第3组)或0 ppm(第4组)N-甲基-N-亚硝基脲(MNU)的饮用水30周,然后改为正常自来水。在第10周、30周和42周处死动物。从第30周开始发现腺瘤样增生和腺癌,并且在第42周时其诱导呈剂量依赖性。这些病变中几乎所有幽门腺细胞类型的细胞免疫组化显示Pg 1含量很少或没有,PAPG中的细胞也是如此,发现在所有实验时间点,每100个外观正常的幽门腺中PAPG的数量与MNU剂量相关。第10周时PAPG的数量与第42周时腺瘤样增生和腺癌的发生率显著相关。通过免疫组化检测第10周时PAPG中溴脱氧尿苷(BrdU)标记来研究增殖情况,结果显示与正常幽门腺相比有所升高(P < 0.05)。本实验中未出现肠化生,结果表明在小鼠中,PAPG可能是参与胃化学致癌作用的癌前病变。